Today is World Malaria Day. This year’s theme: End Malaria for Good.
While 6.8 million malaria deaths were averted between 2000 – 2015, there are still 3.2 billion people who are susceptible to contracting the disease every day and a half million children die from malaria every year. There is a long way to go to save more lives especially for children under the age of five in sub-Saharan African where most deaths occur.
But Trump wants to go even further than his GOP predecessors by slashing spending on global health efforts funded through the United States Agency for International Development (USAID). Deeper family planning retrenchment would, however, put millions of lives at risk.
Launched four years ago, the two clinical trials, known as ASPIRE and The Ring Study, set out to determine how safe and effective the ring was in prevention of HIV infection in women. The ring, which is used for a month at a time, contains an antiretroviral drug called dapivirine that acts by blocking HIV from multiplying.
The studies enrolled close to 4500 women aged 18 to 45 in South Africa, Uganda, Malawi and Zimbabwe. Each study found that the ring helps reduce the risk of HIV infection in women. In ASPIRE, the ring reduced the risk of HIV infection by 27% overall. In The Ring Study, infections were reduced by 31% overall.
The human immunodeficiency virus (HIV) continues to take a tremendous toll on human health, with 37 million people infected and 1.2 million deaths worldwide in 2014. In sub-Saharan Africa, where the HIV epidemic has been most devastating, more than 25 million people are HIV-infected, about 70 percent of the global total.
But as of 2014, only about 11 million people infected with the virus in Africa were receiving treatment with antiretroviral therapy (ART) medications, which can stop the progression of disease and reduce the risk of HIV transmission.
That leaves 14 million people with HIV in sub-Saharan Africa untreated. This is partly because, until recently, most countries have provided ART only for patients who reached a specific threshold in HIV disease progression. And starting ART can be a lengthy and complicated process, leading many patients to drop out of care before they even begin treatment.